Navigation Links
Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan
Date:11/4/2010

3 (the "Registration Statement") (including prospectus) for the offering of Common Shares to which this communication relates shortly after the Record Date.  Non-registered beneficial shareholders are advised to contact their broker, investment dealer or other financial intermediary for details on how to participate in the Plan.  To participate in the Plan, eligible shareholders must return their enrollment forms to the Agent in accordance with the Plan by 5:00 p.m. (Toronto time) on December 8, 2010.

This press release does not and will not constitute an offer to sell or the solicitation of an offer to buy Common Shares.  Valeant intends to file a Registration Statement (including a prospectus) with the Securities and Exchange Commission (the "SEC") for the offering of Common Shares to which this communication relates.  Before investing, eligible shareholders should read the prospectus in that Registration Statement and other documents Valeant has filed with the SEC and with the Canadian Securities Administrators (the "CSA") for more complete information about Valeant and the offering.  These documents may be obtained, free of charge, at the website maintained by the SEC at www.sec.gov and on SEDAR at www.sedar.com.  These documents may also be obtained, free of charge, from Valeant's website (www.valeant.com) under the tab "Investor Relations" and then under the heading "SEC Filings," or by directing a request to Valeant, 7150 Mississauga Road, Mississauga, Ontario, Canada, L5N 8M5, Attention: Investor Relations.  Additionally, these documents will be available from the Agent after the Record Date.  The Agent can be reached at 1-800-387-0825.  This press release is being issued pursuant to and in accordance with Rule 135 under the Securities Act of 1933, as amended.

Important Income-Tax Information f
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Valeant Pharmaceuticals Reports 2010 Third Quarter Financial Results
2. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
3. Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016
4. Valeant and Biovail Announce Results of Special Meetings of Shareholders
5. GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
6. Valeant to Acquire Polish Products
7. Pfizer Declares an 18-Cent Fourth-Quarter 2010 Dividend
8. Techne Corporation Declares Dividend
9. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter and Nine-Months Ended September 30, 2010 and Declares Quarterly Dividend
10. Mylan Declares Quarterly Preferred Stock Dividend
11. Lilly Declares Fourth-Quarter 2010 Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... , April 27, 2015 ... completed filing of a Pre-Marketing Notification Application (510k) with ... BRH-A2 Wound Management System. BRH Medical expects feedback from ... the US market with BRH-A2 following FDA pre-market clearance. ... Motti Oderberg , CEO for BRH Medical, ...
(Date:4/27/2015)... 2015 - The First Company in ... State Intellectual Property Office of China ... - A New Treatment Which Offers Hope for ... - About 20% of Elderly Urban Chinese Suffer From Peripheral ... Higher Than in Men. CLI is a Progressive Form of ...
(Date:4/26/2015)... 26, 2015  Ikonopedia announced today that its ... have been selected for use by BelleBridge, which ... and diagnostic examinations. Ikonopedia will showcase its suite ... Breast Imaging,s SBI/ACR Breast Imaging Symposium in ... (SBI Booth #216). BelleBridge is an ...
Breaking Medicine Technology:BRH Medical, Ltd., Announces Filing of a Pre-Market Submission with the US Food and Drug Administration (FDA) for the BRH-A2 Tissue Management System 2Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 2Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 3Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 4Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services 2Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services 3Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services 4
... June 3, 2011 Rep. Ed Whitfield, R-Ky., has ... will set federal minimum education and certification standards in ... and delivering all medical imaging examinations and radiation therapy ... ( CARE ) in Medical Imaging and Radiation Therapy ...
... Va., June 3, 2011 Clinical Care Options (CCO), ... esteemed breast cancer experts will present a poster titled, ... for guiding choice of systemic adjuvant treatment (adj TX) ... " at the American Society of Clinical Oncology ...
Cached Medicine Technology:Medical Imaging and Radiation Therapy Personnel Certification Bill Introduced in Congress 2Medical Imaging and Radiation Therapy Personnel Certification Bill Introduced in Congress 3CCO Presents Results of Clinician Utilization of Online Decision Support Tool Presented as Part of 2011 ASCO Annual Meeting in Chicago 2CCO Presents Results of Clinician Utilization of Online Decision Support Tool Presented as Part of 2011 ASCO Annual Meeting in Chicago 3
(Date:4/27/2015)... PREVENT Life Safety, America’s premier provider of life ... addition of an account manager in Houston. In order ... customer base, Curtis Rice, an experienced sales professional, has ... Curtis has been added to the team to generate ... area and beyond. , Curtis brings with ...
(Date:4/27/2015)... 27, 2015 Health conscious businesses in ... first-of-its-kind bakery right on their doorstep, which will offer ... on restrictive and low-carbohydrate diets. This nut-based ... starch free, and will use only natural sweeteners like ... 2015, strives to provide specialty food that is currently ...
(Date:4/27/2015)... April 27, 2015 Jvion, the Atlanta-based ... Atlanta Pacesetter and recognized as one of the top ... award, which is presented by the Atlanta Business Chronicle, ... accelerate Atlanta’s status as an economic capital and employment ... success is spurred by the growing need to improve ...
(Date:4/26/2015)... York (PRWEB) April 26, 2015 ... 21, 2015 in the U.S. District Court, Northern ... lawsuits ( http://www.testosteronelawsuithub.com/ ) have been consolidated ... to court documents, matters addressed included the intention ... of claims involving their products on preemption grounds, ...
(Date:4/26/2015)... has released a new blog post explaining how to find ... to find low cost auto insurance is by comparing quotes. ... in a simple and convenient way. It is no longer ... prices. All the details are now freely available to anyone ... possible to compare online car insurance quotes on a single ...
Breaking Medicine News(10 mins):Health News:PREVENT Life Safety Services Welcomes Curtis Rice as a New Senior Account Manager in Houston, TX 2Health News:Nourish Bakery Serves Up Healthy Eating in Huntsville, Alabama 2Health News:Jvion Named to Top 40 Atlanta 2015 Pacesetters 2Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 2Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 3Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 4Health News:Finding Low Cost Auto Insurance - An Online Guide Provides Tips 2
... Nov. 25 Omnicell, Inc.,(Nasdaq: OMCL ) a ... that Randall A. Lipps, founder, chairman,president & CEO and Rob ... 20th Annual Health Care Conference at The New York Palace ... at 2:30 p.m. ET on,Tuesday, December 2, 2008. , ...
... to make it easier for physicians to participate , ... For the fifth consecutive year, Bridges to Excellence ... physicians for delivering high-quality care, will pay bonuses to ... Commonwealth total more than $2.5 million. The BTE programs ...
... LAKES, N.J., Nov. 25 The Board of Directors of BD ... quarterly dividend of 33 cents per common share, an increase of 4.5 ... be payable on January 2, 2009 to holders of record on December ... would be $1.32 cents per share. , , ...
... Part the Holiday Season , , ... be overwhelming, especially during the busy holiday season. Unfortunately many get ... otherwise be purchased. At airports, it,s easy to wind up ... whether you,re in a rush or have time to spend before ...
... Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced ... will present a,company overview at the Twentieth Annual Piper Jaffray ... EST at The New York Palace Hotel,in New York City. ... live audio webcast or the subsequent archived recording, log,on to ...
... HI ) reported fourth-quarter 2008 revenue of $158.8 million, ... In addition, the,company reported fully diluted earnings per share of ... same period in the prior year. , ... as a general decline in,burials and a lower average product ...
Cached Medicine News:Health News:Omnicell to Present at Piper Jaffray 20th Annual Healthcare Conference 2Health News:Doctors Receive Bonuses for Providing Optimal Care to Patients Through Bridges to Excellence 2Health News:Doctors Receive Bonuses for Providing Optimal Care to Patients Through Bridges to Excellence 3Health News:BD Board Declares Dividend Increase and Authorizes Additional Share Repurchases 2Health News:BD Board Declares Dividend Increase and Authorizes Additional Share Repurchases 3Health News:Nutritionist Claudia Gonzalez Shares Tips for Eating Well On-the-Go During the Busy Holiday Rush 2Health News:Hillenbrand, Inc. Reports Fourth-Quarter Revenue of $159 Million and Earnings Per Share of $0.31 2Health News:Hillenbrand, Inc. Reports Fourth-Quarter Revenue of $159 Million and Earnings Per Share of $0.31 3Health News:Hillenbrand, Inc. Reports Fourth-Quarter Revenue of $159 Million and Earnings Per Share of $0.31 4Health News:Hillenbrand, Inc. Reports Fourth-Quarter Revenue of $159 Million and Earnings Per Share of $0.31 5Health News:Hillenbrand, Inc. Reports Fourth-Quarter Revenue of $159 Million and Earnings Per Share of $0.31 6Health News:Hillenbrand, Inc. Reports Fourth-Quarter Revenue of $159 Million and Earnings Per Share of $0.31 7Health News:Hillenbrand, Inc. Reports Fourth-Quarter Revenue of $159 Million and Earnings Per Share of $0.31 8Health News:Hillenbrand, Inc. Reports Fourth-Quarter Revenue of $159 Million and Earnings Per Share of $0.31 9Health News:Hillenbrand, Inc. Reports Fourth-Quarter Revenue of $159 Million and Earnings Per Share of $0.31 10Health News:Hillenbrand, Inc. Reports Fourth-Quarter Revenue of $159 Million and Earnings Per Share of $0.31 11
... Wampole EBV ELISA test panel ... assays for the determination of ... for Viral Capsid Antigen (VCA), ... Antigen (EBNA). Most Wampole EBV ...
Toxoplasma IgM II ELISA....
ELISA kit for CMV CAP M....
Herpes Simplex Virus 1 IgG ELISA....
Medicine Products: